These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


293 related items for PubMed ID: 15448686

  • 1. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites.
    Zaph C, Uzonna J, Beverley SM, Scott P.
    Nat Med; 2004 Oct; 10(10):1104-10. PubMed ID: 15448686
    [Abstract] [Full Text] [Related]

  • 2. The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development.
    Scott P, Artis D, Uzonna J, Zaph C.
    Immunol Rev; 2004 Oct; 201():318-38. PubMed ID: 15361250
    [Abstract] [Full Text] [Related]

  • 3. Memory may not need reminding.
    Seder RA, Sacks DL.
    Nat Med; 2004 Oct; 10(10):1045-7. PubMed ID: 15459703
    [No Abstract] [Full Text] [Related]

  • 4. Immunologic memory in cutaneous leishmaniasis.
    Scott P.
    Cell Microbiol; 2005 Dec; 7(12):1707-13. PubMed ID: 16309457
    [Abstract] [Full Text] [Related]

  • 5. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
    Moll H, Flohé S, Röllinghoff M.
    Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge.
    Menon JN, Bretscher PA.
    Eur J Immunol; 1996 Jan; 26(1):243-9. PubMed ID: 8566074
    [Abstract] [Full Text] [Related]

  • 7. Mice lacking NK cells develop an efficient Th1 response and control cutaneous Leishmania major infection.
    Satoskar AR, Stamm LM, Zhang X, Satoskar AA, Okano M, Terhorst C, David JR, Wang B.
    J Immunol; 1999 Jun 01; 162(11):6747-54. PubMed ID: 10352294
    [Abstract] [Full Text] [Related]

  • 8. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells.
    Lindenstrøm T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, Seder RA, Rosenkrands I, Andersen P.
    J Immunol; 2009 Jun 15; 182(12):8047-55. PubMed ID: 19494330
    [Abstract] [Full Text] [Related]

  • 9. The p110 delta isoform of phosphatidylinositol 3-kinase controls the quality of secondary anti-Leishmania immunity by regulating expansion and effector function of memory T cell subsets.
    Liu D, Uzonna JE.
    J Immunol; 2010 Mar 15; 184(6):3098-105. PubMed ID: 20154209
    [Abstract] [Full Text] [Related]

  • 10. Chronic parasitic infection maintains high frequencies of short-lived Ly6C+CD4+ effector T cells that are required for protection against re-infection.
    Peters NC, Pagán AJ, Lawyer PG, Hand TW, Henrique Roma E, Stamper LW, Romano A, Sacks DL.
    PLoS Pathog; 2014 Dec 15; 10(12):e1004538. PubMed ID: 25473946
    [Abstract] [Full Text] [Related]

  • 11. Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection.
    Tabbara KS, Peters NC, Afrin F, Mendez S, Bertholet S, Belkaid Y, Sacks DL.
    Infect Immun; 2005 Aug 15; 73(8):4714-22. PubMed ID: 16040984
    [Abstract] [Full Text] [Related]

  • 12. The role of chemokines and accessory cells in the immunoregulation of cutaneous leishmaniasis.
    Moll H.
    Behring Inst Mitt; 1997 Mar 15; (99):73-8. PubMed ID: 9303204
    [Abstract] [Full Text] [Related]

  • 13. Early CD44(hi)CD4+ and CD44(hi)CD8+ T cell numbers and the absence of mannose-rich glycoconjugates determine the protective outcome of anti-leishmanial immunity.
    Kedzierski L, Curtis JM, Kedzierska K.
    Parasitology; 2009 Jul 15; 136(8):833-40. PubMed ID: 19490731
    [Abstract] [Full Text] [Related]

  • 14. Lessons from Leishmania: a model for investigations of CD4+ subset differentiation.
    Reiner SL, Locksley RM.
    Infect Agents Dis; 1992 Feb 15; 1(1):33-42. PubMed ID: 1365527
    [Abstract] [Full Text] [Related]

  • 15. LACK-reactive CD4+ T cells require autocrine IL-2 to mediate susceptibility to Leishmania major.
    Gumy A, Aseffa A, Rachinel N, Breton M, Otten L, Tacchini-Cottier F, Röcken M, Doyen N, Acha-Orbea H, Locksley RM, MacDonald HR, Launois P, Louis J.
    Eur J Immunol; 2006 Jun 15; 36(6):1465-73. PubMed ID: 16637008
    [Abstract] [Full Text] [Related]

  • 16. Effect of chronic ethanol consumption on protective T-helper 1 and T-helper 2 immune responses against the parasites Leishmania major and Strongyloides stercoralis in mice.
    Krolewiecki AJ, Leon S, Scott PA, Nolan TJ, Schad GA, Abraham D.
    Alcohol Clin Exp Res; 2001 Apr 15; 25(4):571-8. PubMed ID: 11329498
    [Abstract] [Full Text] [Related]

  • 17. Regulatory T cells: mediating compromises between host and parasite.
    Sakaguchi S.
    Nat Immunol; 2003 Jan 15; 4(1):10-1. PubMed ID: 12496970
    [No Abstract] [Full Text] [Related]

  • 18. Unidirectional development of CD8+ central memory T cells into protective Listeria-specific effector memory T cells.
    Huster KM, Koffler M, Stemberger C, Schiemann M, Wagner H, Busch DH.
    Eur J Immunol; 2006 Jun 15; 36(6):1453-64. PubMed ID: 16637009
    [Abstract] [Full Text] [Related]

  • 19. Vaccination with plasmacytoid dendritic cells induces protection against infection with Leishmania major in mice.
    Remer KA, Apetrei C, Schwarz T, Linden C, Moll H.
    Eur J Immunol; 2007 Sep 15; 37(9):2463-73. PubMed ID: 17705130
    [Abstract] [Full Text] [Related]

  • 20. Tissue trafficking patterns of effector memory CD4+ T cells in rheumatoid arthritis.
    Zhang X, Nakajima T, Goronzy JJ, Weyand CM.
    Arthritis Rheum; 2005 Dec 15; 52(12):3839-49. PubMed ID: 16329093
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.